With regard to Health Canada’s (HC) and the Public Health Agency of Canada’s (PHAC) decision to withdraw the market authorization of and to destroy the COVID-19 XBB.1.5 vaccines and future assessment of upcoming mRNA vaccines: (a) are there material differences between the XBB.1.5 COVID-19 vaccines and the new 2024-2025 formulation beyond the mRNA coding for a different spike protein strain; (b) if (a) is affirmative, what are the differences; (c) if the answer to (a) is affirmative, how will Canadians processing claims against the vaccine manufacturers be able to prove their allegations when physical evidence is required and has been destroyed; (d) what is the estimated number of COVID-19 vaccine vials that will be destroyed, broken down by manufacturer (Pfizer, Moderna, AstraZeneca, others); (e) what is the estimated dollar cost to Canadians to destroy these vaccine products, per vaccine and in total; (f) what is the regulatory process for COVID-19 vaccines which resulted in a “contractual obligation for Health Canada to withdraw all XBB products from the market until a lot could be released and distributed in Canada” (Global news); (g) what is the contractual obligation in (f) and with whom; (h) will provinces be able to order any interim supply of the COVID-19 XBB vaccines and, if not, why not; (i) with respect to the statement made by Pfizer/BioNTech on October 20, 2023, found on page 56 of Access to Information and Privacy (ATIP) 2024-000097-2024-08-22, that Pfizer “would be open to discuss the outcome from the plasmid backbone modification evaluation with Health Canada”, does HC expect the removal of the SV40 sequences from the updated Pfizer/BioNTech COVID-19 vaccines for 2024-25; (j) is HC considering the assessment of future mRNA-based vaccines to continue under the Centre for Vaccines, Clinical Trials and Biostatistics or to be transferred to another Centre or Department within Biologic and Radiopharmaceutical Drugs Directorate or elsewhere, and, if so, what would be the criteria or rationale?
In the House of Commons on November 25th, 2024. See this statement in context.